U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07680023) titled 'Amnion Membrane Powder Mohs Study' on June 25.
Brief Summary: The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery on the scalp.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Wound Heal
Intervention:
DRUG: Amnion Membrane Powder
amnion membrane power dose of 0.26 mg/mm3 applied during MOHS scalp surgery
DRUG: Standard of Care
aquaphor ointment applied during MOHS scalp surgery
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Wake Forest University Health Sciences
Disclaimer: Curated by HT Syndicati...